Direct comparison of changes in bone density and bone turnover markers in postmenopausal women with low bone mass treated with 6-monthly denosumab or weekly alendronate (Fosamax®.

被引：0
|
作者：
Deal, C. [1 ]
Brown, J. P. [2 ]
Recker, R. [3 ]
Prince, R. [4 ]
Kiel, D. P. [5 ,6 ]
Alvaro-Gracia, J. M. [7 ]
de Gregorio, L. H. [8 ]
Hadji, P. [9 ]
Hofbauer, L. C. [10 ]
Wang, H. [11 ]
Austin, M. [11 ]
Newmark, R. [11 ]
Libanati, C. [11 ]
Wagman, R. B. [12 ,13 ]
Martin, J. San [11 ]
Bone, H. G. [14 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] CHUQ Laval Univ, Quebec City, PQ, Canada
[3] Creighton Univ, Omaha, NE 68178 USA
[4] Univ Western Australia, Sir Charles Gairdner Hosp, Perth, WA 6009, Australia
[5] Hebrew SeniorLife, Inst Aging Res, Boston, MA USA
[6] Harvard Univ, Sch Med, Boston, MA USA
[7] Hosp Princesa, Madrid, Spain
[8] SYNARC CCBR, Rio De Janeiro, Brazil
[9] Univ Marburg, Marburg, Germany
[10] Tech Univ Dresden, Med Ctr, Dresden, Germany
[11] Amgen Inc, Thousand Oaks, CA 91320 USA
[12] Amgen Inc, San Francisco, CA USA
[13] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[14] Michigan Bone & Mineral Clin, Detroit, MI USA
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S940 / S940
页数：1
相关论文
共 50 条
  • [1] ASSESSMENT OF BONE MINERAL DENSITY AND BONE TURNOVER MARKERS IN POSTMENOPAUSAL WOMEN TRANSITIONED FROM ALENDRONATE TO DENOSUMAB
    Roux, C.
    Brown, J. P.
    Kendler, D. L.
    Lillestol, M.
    Siddhanti, S.
    Man, H. S.
    Martin, J. San
    Bone, H. G.
    Benhamou, C. L.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 10 - 11
  • [2] Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
    Bone, Henry G.
    Bolognese, Michael A.
    Yuen, Chui Kin
    Kendler, David L.
    Miller, Paul D.
    Yang, Yu-Ching
    Grazette, Luanda
    San Martin, Javier
    Gallagher, J. Christopher
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (04): : 972 - 980
  • [3] Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial
    Brown, Jacques P.
    Prince, Richard L.
    Deal, Chad
    Recker, Robert R.
    Kiel, Douglas P.
    de Gregorio, Luiz H.
    Hadji, Peyman
    Hofbauer, Lorenz C.
    Alvaro-Gracia, Jose M.
    Wang, Huei
    Austin, Matthew
    Wagman, Rachel B.
    Newmark, Richard
    Libanati, Cesar
    Martin, Javier San
    Bone, Henry G.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2009, 24 (01) : 153 - 161
  • [4] Comparison of changes in bone mineral density and bone turnover marker with alendronate once-weekly and bi-weekly in postmenopausal Korean women
    Oh, H.
    Joo, I.
    Yu, B.
    Lee, S.
    Lee, H.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S332 - S332
  • [5] Comparison of changes in bone mineral density and bone turnover marker with alendronate once-weekly and bi-weekly in postmenopausal Korean women
    Oh, H.
    Joe, I.
    Yu, B.
    Kim, K.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S133 - S133
  • [6] Denosumab effects on bone density and turnover in postmenopausal women with low bone mass with or without previous treatment
    Tsourdi, Elena
    Makras, Polyzois
    Rachner, Tilman D.
    Polyzos, Stergios
    Rauner, Martina
    Mandanas, Stylianos
    Hofbauer, Lorenz C.
    Anastasilakis, Athanasios D.
    BONE, 2019, 120 : 44 - 49
  • [7] Denosumab in treatment-naive and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers
    Anastasilakis, Athanasios D.
    Polyzos, Stergios A.
    Efstathiadou, Zoe A.
    Sauvidis, Matthaios
    Sakellariou, Grigorios T.
    Papatheoclorou, Athanasios
    Kokkoris, Panagiotis
    Makras, Polyzois
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2015, 64 (10): : 1291 - 1297
  • [8] Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women Transitioning From Alendronate Therapy
    Kendler, David L.
    Roux, Christian
    Benhamou, Claude Laurent
    Brown, Jacques P.
    Lillestol, Michael
    Siddhanti, Suresh
    Man, Hoi-Shen
    Martin, Javier San
    Bone, Henry G.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (01) : 72 - 81
  • [9] Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis
    Sanchez, A.
    Brun, L. R.
    Salerni, H.
    Costanzo, P. R.
    Gonzalez, D.
    Bagur, A.
    Oliveri, B.
    Zanchetta, M. B.
    Farias, V.
    Maffei, L.
    Premrou, V.
    Mansur, J. L.
    Larroude, M. S.
    Sarli, M. A.
    Rey, P.
    Ulla, M. R.
    Pavlove, M. M.
    Karlsbrum, S.
    Brance, M. L.
    JOURNAL OF OSTEOPOROSIS, 2016, 2016
  • [10] Effects of raloxifene and alendronate on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis
    Johnell, O
    Lu, Y
    Seeman, E
    Reginster, J
    Scheele, W
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S184 - S184
12345